摘要
川崎病,又称皮肤黏膜淋巴结综合征,是一种原因未明的以变态反应性全身血管炎为主要病理改变的急性发热出疹性疾病。近年来其发病率逐年升高,在发达国家,川崎病已取代风湿热成为儿童获得性心脏病的主要原因〔1〕。
出处
《临床心血管病杂志》
CAS
CSCD
北大核心
2011年第3期163-165,共3页
Journal of Clinical Cardiology
参考文献10
-
1SUGIMURA T,KATO H,INOUE O,et al.Intravascular ultrasound of coronary arteries in children:assessment of the wall morphology and the lumen after kawasaki disease[J].Circulation,1994,89:258-265.
-
2OU C Y,TSENG Y F,LEE C L,et al.Significant relationship between serum high-sensitivity C-reactive protein,high-density lipoprotein cholesterol levels and chidren with Kawasaki disease and coronary artery lesions[J].J Formos Med Assoc,2009,108:719-724.
-
3MITANI Y,SAWADA H,HAYAKAWA H.Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease:association between inflammation and late coronary sequelae in Kawasaki disease[J].Circulation,2005,111:38-43.
-
4KATE H,LNOUE O,KAWASAKI T,et al.Adult coronary artery disease probably due to childhood Kawasaki disease[J].Lanect,1992,340:1127-1129.
-
5Committee.Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J].Pediatr Int,2005,47:711-732.
-
6CHEUNG Y F,FUO K,WOO C W,et al.Oxidative stress in children late after Kawasaki disease relationship with carotid atheroscleross and stiffness[J].BMC Pediatr,2008,8:20-23.
-
7MCMAHON M A,WYNNE B,MURPHY G M,et al.Recurrence of Kawasaki disease in an adult patient with cholecystitis[J].Ir Med J,2007,100:400-401.
-
8IEMURA M,ISHII M,SUGIMURA T,et al.Long term consequences of regressed coronary aneurysms after Kawasaki disease:vascular wall morphology and function[J].Heart,2000,83:307-311.
-
9CUNHA B A,PHEREZ F M,ALEXIADIS V,et al.Adult Kawasaki's disease with myocarditis,splenomegaly,and highly elevated serum ferritin levels[J].Heart Lung,2010,39:164-172.
-
10NEWBURGER J W,TAKAHASHI M,GERBER M A,et al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart Association[J].Circulation,2004,110:2747-2771.
同被引文献28
-
1齐永秀,赵汉平,朱玉云.双嘧达莫的药理作用与临床应用进展[J].泰山医学院学报,2005,26(4):394-396. 被引量:29
-
2胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
-
3LEVI M, VAN DER POLL T, B(JLLER H R. Bidi- rectional relation between inflammation and coagula- tion[J]. Circulation, 2004,109 .. 2698- 2704.
-
4杨作成.川崎病[M]//叶志中,李博,何伟珍.儿童风湿病学.北京:人民卫生出版社,2009:286-292.
-
5ROWLEY A H, SHULMAN S T. Pathogenesis and management of Kawasaki disease[J]. Expert Rev Anti Infect Ther, 2010,8 ~ 197- 203.
-
6CASTAMAN G, GHIOTTO R, DUGA S, et al. A novel fibrinogen gamma chain mutation (gamma 239 Gin- His) is the cause of dysfibrinogenemia Vi- cenza[J]. J Thromb Haemost, 2005,3 : 600- 601.
-
7里震,包进.纤维蛋白原13-455G/A基因多态性与冠心病的相关性[J].中国老年医学杂志,2008,28(24):2472-2473.
-
8邹宏丽,宋玉强,杨凤.冠心病病人纤维蛋白原β-148C/T基因多态性的检测[J].齐鲁医学杂志,2007,22(5):397-398. 被引量:1
-
9Tracke CE, Burgner D, Kuipers IM, et al. Management of a- cute and refractory Kawasaki disease [ J ] . Expert Rev Anti Infect Ther, 2012, 10 (10) : 1203 -1215.
-
10Kumar A, Sivakanesan R, Gunasekera S. Ischemia modified al- bumin:a potent marker in acute myocardial infarction in normo- lipidaemic[ J]. Pak J Med Sci ,2008,24:364 - 367.
引证文献3
-
1陈碧仪,李卓颖,江杰,陈志衡,陈佳,田朗,黄利华,杨作成.纤维蛋白原β链-148C/T和-455G/A基因多态性与川崎病的相关性[J].临床心血管病杂志,2013,29(5):387-390. 被引量:5
-
2张翼飞,刘丹.IMA和CK-MB在川崎病伴冠状动脉损伤患儿急性期血清中的表达及相关性研究[J].中国妇幼保健,2014,29(25):4087-4089. 被引量:4
-
3武海江,孙永法,陈清.双嘧达莫联合丙种球蛋白及阿司匹林治疗川崎病患儿的效果研究[J].中国药物滥用防治杂志,2023,29(9):1576-1580. 被引量:2
二级引证文献11
-
1何志萍,吴雅娟,李翠霞,郑素仪,黎瑞雪.丙种球蛋白联合阿司匹林对川崎病合并冠状动脉损伤患者T细胞亚群的影响[J].热带医学杂志,2016,16(4):510-513. 被引量:6
-
2曾才秀,詹霞,周进,谢圭,袁海斌,周钗,杨作成.淋巴毒素α基因rs1800683G>A位点多态性与川崎病的关联性研究[J].中国儿童保健杂志,2016,24(5):472-474.
-
3陈洁,余更生.川崎病合并冠状动脉病变的研究进展[J].现代医药卫生,2017,33(11):1664-1666. 被引量:8
-
4万芳,高应东.缺血修饰白蛋白的临床应用进展[J].标记免疫分析与临床,2017,24(7):823-826. 被引量:17
-
5谢圭,杨作成,刘琳,詹霞,曾萍,何艳娟,成亮,黄利华,陈淳媛.IL-12B基因rs3212227位点多态性与川崎病及其并发冠状动脉损伤的关联性研究[J].中国免疫学杂志,2018,34(9):1372-1376. 被引量:5
-
6谭卫群,刘琮,孟祥春,萧敏,谢颖.普奈洛尔联合左卡尼汀治疗川崎病合并冠状动脉瘤的疗效分析[J].中国现代药物应用,2019,13(12):107-108. 被引量:1
-
7陈棉,方声,王敏娜,朱海燕.血清IMA、Lp-PLA2对川崎病患儿冠状动脉损伤的诊断价值[J].中国妇幼保健,2019,34(21):4948-4951. 被引量:5
-
8孙欣娜,于泊,杨青,成佳文,胡正权,杨茜芸,张世娜.川崎病CK-MB、NT-proBNP、H-FABP和冠状动脉Z值的变化及其与冠脉病变的相关性研究[J].临床和实验医学杂志,2022,21(13):1384-1387. 被引量:5
-
9高冬燕.高剂量丙种球蛋白联合双嘧达莫改善川崎病患儿凝血功能及炎症因子的效果[J].中国医药指南,2024,22(11):94-97.
-
10崔新慧.双嘧达莫联合免疫球蛋白与阿司匹林治疗川崎病患儿的效果[J].中国民康医学,2024,36(10):92-95.
-
1翁永青,王英姿.川崎病患儿D-二聚体、血沉C-反应蛋白的变化及其意义[J].浙江临床医学,2012,14(4):428-429. 被引量:2
-
2齐悦,贡欣,常亚彬,徐兆峰,刘凤英.实时三维超声心动图定量评价川崎病左室收缩同步性[J].天津医药,2009,37(11):975-976. 被引量:1
-
3任玉琴,王翠玲,杨建春.川崎病8例误诊分析[J].中国现代医药科技,2003,3(3):27-27.
-
4吕吉元,范春雨.第2例——少年胸闷、胸痛[J].中华心血管病杂志,2003,31(3):233-235.
-
5杨波,李世钢,林华.大剂量丙种球蛋白对川崎病患儿血管氧化应激的影响[J].临床儿科杂志,2011,29(2):126-126. 被引量:8
-
6常宇娟.川崎病36例的临床分析[J].临床和实验医学杂志,2009,8(7):142-143.
-
7何修宇.儿童川崎病20例报告[J].中国基层医药,2009,16(4):704-704. 被引量:3
-
8康莉.皮肤黏膜淋巴结综合征的护理[J].现代中西医结合杂志,2004,13(17):2358-2358.
-
9赵发忠,刘新义.成人先天性心脏病X线诊断评价与临床误诊分析[J].医用放射技术杂志,2005(4):87-88. 被引量:1
-
10陈静华.早期应用大剂量丙种球蛋白冲击治疗川崎病患儿的护理[J].中华现代护理杂志,2010,16(23):2797-2798. 被引量:2